|
End-of-day quote
Other stock markets
|
||
| - EGP | - |
|
| 05-21 | The Arab Drug Company Reports Earnings Results for the Nine Months Ended March 31, 2026 | CI |
| 04-30 | Arab Drug Company 9-month net profit EGP 196.4 million | RE |
| Market Cap | 2.89B 58.73M 51.41M 47.46M 44.27M 83.41M 5.55B 84.9M 569M 221M 2.74B 221M 216M 9.55B | P/E 2024 |
5.46x | P/E 2025 | 6.08x |
|---|---|---|---|---|---|
| Enterprise Value | 3.32B 67.54M 59.12M 54.58M 50.91M 95.92M 6.39B 97.63M 655M 254M 3.15B 254M 248M 10.98B | EV / Sales 2024 |
0.98x | EV / Sales 2025 | 1.47x |
| Free-Float |
19.57% | Yield 2024 |
10.4% | Yield 2025 | 4.14% |
| Manager | Title | Age | Since |
|---|---|---|---|
Tariq Ali
DFI | Director of Finance/CFO | - | - |
Yosef Omr Amer
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | 29/09/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.48% | +8.34% | +53.87% | +155.75% | 1,070B | |
| -1.76% | +6.23% | +66.27% | +53.44% | 611B | |
| -1.05% | +7.19% | +35.57% | +86.77% | 445B | |
| -1.39% | +4.18% | +31.11% | +23.88% | 329B | |
| +0.34% | +2.01% | +36.42% | +36.78% | 290B | |
| -0.17% | +1.80% | +29.30% | +42.96% | 287B | |
| +1.56% | +2.52% | -27.14% | -40.99% | 213B | |
| +0.44% | +4.35% | +29.69% | +63.10% | 195B | |
| +0.01% | +1.03% | +13.95% | +63.93% | 157B | |
| Average | -0.46% | +5.04% | +29.89% | +53.96% | 399.58B | |
| Weighted average by Cap. | -1.11% | +6.67% | +40.42% | +78.50% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 786M 15.99M 13.99M 12.92M 12.05M 22.7M 1.51B 23.11M 155M 60.16M 746M 60.07M 58.73M 2.6B | 1.12B 22.76M 19.92M 18.39M 17.15M 32.32M 2.15B 32.9M 221M 85.64M 1.06B 85.51M 83.6M 3.7B |
| Net income | 103M 2.09M 1.83M 1.69M 1.58M 2.97M 198M 3.03M 20.28M 7.87M 97.65M 7.86M 7.69M 340M | 228M 4.64M 4.06M 3.75M 3.5M 6.59M 439M 6.7M 44.95M 17.45M 216M 17.42M 17.03M 754M |
| Net Debt | 284M 5.79M 5.07M 4.68M 4.36M 8.22M 547M 8.37M 56.1M 21.78M 270M 21.75M 21.26M 941M | 433M 8.81M 7.71M 7.12M 6.64M 12.51M 833M 12.74M 85.39M 33.15M 411M 33.1M 32.36M 1.43B |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
